A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
European Myeloma Network B.V.
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Janssen Research & Development, LLC
Celgene
Dartmouth-Hitchcock Medical Center
University of Arkansas
SWOG Cancer Research Network
University of Arkansas
Janssen Scientific Affairs, LLC
Fondazione EMN Italy Onlus
Fondazione EMN Italy Onlus
The Affiliated People's Hospital of Ningbo University
Fondazione EMN Italy Onlus
Weill Medical College of Cornell University
University of Leeds
Grupo de Estudos Multicentricos em Onco-Hematologia
Jinling Hospital, China
University of Arkansas
Nantes University Hospital
SWOG Cancer Research Network
Janssen-Cilag G.m.b.H
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northwestern University
Grupo de Estudos Multicentricos em Onco-Hematologia
University Hospital, Caen
National Cancer Institute (NCI)